论文部分内容阅读
目的观察与探讨依那普利叶酸片辅治H型高血压致急性脑梗死患者的临床效果。方法选取2015年12月~2017年1月期间于我院就诊及治疗的100例H型高血压致急性脑梗死患者作为研究对象,按照随机数字表法分为两组,每组各50例,对照组患者给予瑞舒伐他汀加硝苯地平缓释片治疗,观察组患者在对照组的基础上给予依那普利叶酸片辅治,对比并分析两组患者的效果。结果观察组患者治疗后MDA水平、SOD水平、NO水平、ET水平明显优于对照组,差异有统计学意义(P<0.05),观察组患者治疗后的血浆HCY水平、Barthel评分、NIHSS评分明显优于对照组,差异有统计学意义(P<0.05)。结论对H型高血压致急性脑梗死患者进行常规治疗的同时,增加使用依那普利叶酸片辅助治疗的效果更佳。
Objective To observe and discuss the clinical effect of enalapril folate in treating patients with acute cerebral infarction complicated by Hypertension. Methods A total of 100 patients with Hypertension-induced acute cerebral infarction who were treated and treated in our hospital from December 2015 to January 2017 were enrolled in this study. Patients were divided into two groups according to a random number table (50 patients in each group) Patients in the control group were given rosuvastatin and nifedipine sustained-release tablets. Patients in the observation group were given enalapril folate tablets on the basis of the control group, and the effects of both groups were compared and analyzed. Results After treatment, the levels of MDA, SOD, NO and ET in the observation group were significantly better than those in the control group (P <0.05). The levels of plasma HCY, Barthel score and NIHSS score in the observation group were significantly higher than those in the control group Better than the control group, the difference was statistically significant (P <0.05). Conclusions The routine treatment of Hypertension patients with acute cerebral infarction, while increasing the use of enalapril folic acid tablets adjuvant therapy is better.